Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas
1996

Effects of Chemotherapy on Glioma Spheroids

Sample size: 7 publication Evidence: moderate

Author Information

Author(s): P Kaaijk, D Troost, OJ de Boer, P Van Amstel, PJM Bakker, S Leenstra, DA Bosch

Primary Institution: Academic Medical Center, University of Amsterdam

Hypothesis

Do daunorubicin and doxorubicin have more significant effects on organotypic multicellular spheroids of gliomas compared to BCNU?

Conclusion

Daunorubicin and doxorubicin are effective in destroying glioma spheroids, while BCNU shows minimal effects.

Supporting Evidence

  • Daunorubicin and doxorubicin caused significant tissue destruction in glioma spheroids.
  • BCNU did not induce significant histological damage to the spheroids.
  • All gliomas were negative for P-glycoprotein and multidrug resistance-related protein.

Takeaway

This study found that two cancer drugs, daunorubicin and doxorubicin, can hurt brain tumor cells, but another drug, BCNU, doesn't work as well.

Methodology

Organotypic multicellular spheroids from seven glioma specimens were treated with BCNU, daunorubicin, or doxorubicin, and analyzed for histology and cell proliferation.

Limitations

The study only included seven patients, and the results may not be generalizable to all glioma types.

Participant Demographics

One astrocytoma grade II, one oligodendroglioma, and five glioblastomas multiforme from seven patients.

Statistical Information

P-Value

p<0.03

Statistical Significance

p<0.03

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication